After oxygen, what is the first drug administered for a patient in ventricular fibrillation who has not responded to defibrillation?

After oxygen, what is the first drug administered for a patient in ventricular fibrillation who has not responded to defibrillation?

• A. Lidocaine or amiodarone
• B. Epinephrine or Vasopressin
• C. Sodium bicarbonate
• D. Atropine sulfate

Answer: (B)

When a patient is in ventricular fibrillation and defibrillation hasn’t worked, the priority is to improve perfusion during CPR. A vasopressor given early helps raise aortic diastolic pressure and thus coronary and cerebral perfusion, increasing the chance of return of spontaneous circulation. Epinephrine is the standard first-choice drug because its alpha-adrenergic vasoconstrictive effects boost perfusion during CPR (and it also has beta-1 effects, but the key benefit here is improved perfusion). Vasopressin is also an option and can replace the first dose of epinephrine in some protocols, providing another mechanism to elevate perfusion pressures. This focus on perfusion during chest compressions is why these drugs are chosen as the initial pharmacologic step after defibrillation attempts fail. Lidocaine or amiodarone are antiarrhythmics used to manage persistent or recurrent VF/VT after initial defibrillation attempts, not the immediate first drug. Sodium bicarbonate is not routinely indicated in cardiac arrest and is reserved for specific situations, such as prolonged arrest with acidosis or certain metabolic disturbances. Atropine is reserved for bradycardia, not shockable rhythms like VF.

When a patient is in ventricular fibrillation and defibrillation hasn’t worked, the priority is to improve perfusion during CPR. A vasopressor given early helps raise aortic diastolic pressure and thus coronary and cerebral perfusion, increasing the chance of return of spontaneous circulation. Epinephrine is the standard first-choice drug because its alpha-adrenergic vasoconstrictive effects boost perfusion during CPR (and it also has beta-1 effects, but the key benefit here is improved perfusion). Vasopressin is also an option and can replace the first dose of epinephrine in some protocols, providing another mechanism to elevate perfusion pressures. This focus on perfusion during chest compressions is why these drugs are chosen as the initial pharmacologic step after defibrillation attempts fail.

Lidocaine or amiodarone are antiarrhythmics used to manage persistent or recurrent VF/VT after initial defibrillation attempts, not the immediate first drug. Sodium bicarbonate is not routinely indicated in cardiac arrest and is reserved for specific situations, such as prolonged arrest with acidosis or certain metabolic disturbances. Atropine is reserved for bradycardia, not shockable rhythms like VF.